TELA BIO INC (TELA) Stock Balance Sheet
NASDAQ:TELA - Nasdaq - US8723811084 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 42.83M | 52.67M | 46.73M | 42.02M | 43.93M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | 10.56M | 10.10M | 9.74M | 6.62M | 4.23M | |||
| Inventories | 13.53M | 12.78M | 13.16M | 11.79M | 7.66M | |||
| Other Current Assets | 2.82M | 2.52M | 2.10M | 2.02M | 3.23M | |||
| Total Current Assets | 69.75M | 78.07M | 71.73M | 62.45M | 59.06M | |||
| Non-Current Assets | ||||||||
| PPE Net | 3.88M | 4.08M | 3.94M | 2.91M | 1.19M | |||
| Intangibles | 1.64M | 1.74M | 2.12M | 2.50M | 2.30M | |||
| Other Non-Current Assets | 1.98M | 2.68M | 265.00K | N/A | N/A | |||
| Total Non-Current Assets | 7.51M | 8.50M | 6.32M | 5.41M | 3.48M | |||
| TOTAL ASSETS | 77.25M | 86.57M | 78.05M | 67.86M | 62.54M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 12.53M | 13.45M | 15.30M | 10.87M | 8.16M | |||
| Accounts Payable | 4.00M | 2.15M | 1.67M | 1.53M | 2.41M | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 16.54M | 15.60M | 16.97M | 12.40M | 10.58M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 41.27M | 41.12M | 40.52M | 39.92M | 31.49M | |||
| Other Non-Current Liabilities | 1.32M | 1.39M | 1.69M | 1.23M | 380.00K | |||
| Total Non-Current Liabilities | 42.59M | 42.51M | 42.20M | 41.15M | 31.87M | |||
| TOTAL LIABILITIES | 59.13M | 58.11M | 59.17M | 53.55M | 42.45M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -369.99M | -358.73M | -320.89M | -274.23M | -229.93M | |||
| Additional Paid In Capital | 387.99M | 387.06M | 339.65M | 288.36M | 250.06M | |||
| Common Shares | 40.00K | 39.00K | 24.00K | 20.00K | 20.00K | |||
| Other Shareholders' Equity | 91.00K | 90.00K | 91.00K | 150.00K | -50.00K | |||
| Shares Outstanding | 39.55M | 39.40M | 24.49M | 19.17M | 14.53M | |||
| Tangible Book Value per Share | 0.42 | 0.68 | 0.68 | 0.62 | 1.23 | |||
| Total Shareholders' Equity | 18.12M | 28.46M | 18.88M | 14.31M | 20.10M | |||
| TOTAL LIABILITIES AND EQUITY | 77.25M | 86.57M | 78.05M | 67.86M | 62.54M | |||
| Statistics | ||||||||
| Debt/Equity | 2.28 | 1.45 | 2.15 | 2.79 | 1.57 | |||
| Current Ratio | 4.22 | 5.01 | 4.23 | 5.04 | 5.58 | |||
| Return On Assets (ROA) | -56.24% | -43.71% | -59.79% | -65.28% | -53.21% | |||
| Return On Equity (ROE) | -239.72% | -132.97% | -247.15% | -309.57% | -165.57% | |||
All data in USD , ROIC based on taxRate of 0.21